FDA Adverse Event Injury Summary report: N

G7 LONGEVITY HIGH WALL 32MM E

MDR report key: 17209217 · Received June 27, 2023

Report

Report Number
0001822565-2023-01702
Event Type
Injury
Date Received
June 27, 2023
Date of Event
October 31, 2022
Report Date
May 21, 2025
Manufacturer
ZIMMER BIOMET, INC.
Product Code
LPH
UDI-DI
00889024519275
PMA / PMN Number
K190660
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. REPORTED EVENT WAS CONFIRMED BY REVIEW OF MEDICAL RECORDS. MEDICAL RECORDS WERE PROVIDED AND REVIEWED BY A HEALTH CARE PROFESSIONAL. REVIEW OF THE AVAILABLE RECORDS IDENTIFIED THE FOLLOWING: AN INITIAL RIGHT THA WAS PERFORMED ON (B)(6) 2022. 3 WEEKS POST OP, THE PATIENT WAS PRESCRIBED OTC TOPICAL MEDICATION FOR PAIN WHICH IS A NORMAL FINDING. SUBSEQUENTLY ON (B)(6) 2022, THE HIP DISLOCATED WHILE IN THE SHOWER AND AN ABDUCTION BRACE WAS ORDERED FOR 6 WEEKS. THE PATIENT DISLOCATED AGAIN ON (B)(6) 2023 AND ANOTHER BRACE WAS ORDERED. NO REVISION HAS OCCURRED TO DATE. RADIOGRAPHS WERE PROVIDED AND REVIEWED BY A HEALTH CARE PROFESSIONAL. REVIEW OF THE AVAILABLE RECORDS IDENTIFIED THE FOLLOWING: RIGHT TOTAL HIP ARTHROPLASTY WITH DEVELOPING RADIOLUCENCY ALONG THE ACETABULAR CUP WHICH COULD INDICATE LOOSENING. DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED. IT WAS REPORTED THE PATIENT DISLOCATED DUE TO BENDING, HOWEVER THAT OCCURRED MORE THAN 6 WEEKS POST OP. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Additional Manufacturer Narrative · 0

(B)(4). D10: CAT #: 00877503202 / BIOLOX® DELTA, CERAMIC FEMORAL HEAD, M, ø 32/0, TAPER 12/14 / 3102189. THE DEVICE WILL NOT BE RETURNED FOR ANALYSIS; HOWEVER, AN INVESTIGATION OF THE REPORTED EVENT IS IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETED, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL AND/OR CORRECTED INFORMATION. UPDATED: G3, G6, H2, H3, H6. NO PRODUCT WAS RETURNED OR PICTURES PROVIDED; VISUAL AND DIMENSIONAL EVALUATIONS COULD NOT BE PERFORMED. REVIEW OF COMPLAINT HISTORY FOUND NO ADDITIONAL RELATED ISSUES FOR THIS ITEM AND THE REPORTED PART AND LOT COMBINATION. ADDITIONAL MEDICAL RECORDS WERE PROVIDED AND REVIEWED BY A HEALTH CARE PROFESSIONAL. REVIEW OF THE AVAILABLE RECORDS IDENTIFIED THE FOLLOWING: THE PATIENT EXPERIENCED REPEAT DISLOCATIONS, HOWEVER LYSIS, LOOSENING OR WEAR WAS NOT NOTED. A REVISION HAS NOT BEEN PERFORMED AT THIS TIME. ROOT CAUSE UNCHANGED. THIS COMPLAINT WAS CONFIRMED BASED ON THE PROVIDED MEDICAL RECORDS. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Description of Event or Problem · 0

IT WAS REPORTED A PATIENT WAS PRESCRIBED A HIP ABDUCTION BRACE APPROXIMATELY TWO MONTHS¿ POST IMPLANTATION DUE TO A DISLOCATION, TO BE WORN FOR SIX WEEKS. SUBSEQUENTLY, THE PATIENT UNDERWENT AN INTERNAL REDUCTION APPROXIMATELY EIGHT MONTHS¿ POST IMPLANTATION DUE TO A RECURRING DISLOCATION. THE PATIENT WAS ALSO PRESCRIBED AN ABDUCTION BRACE AFTER THE PROCEDURE. TO DATE, NO REVISION HAS BEEN SCHEDULED AND ALL IMPLANTS REMAIN IN PLACE. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION IS AVAILABLE.

Description of Event or Problem · 0

NO ADDITIONAL EVENT INFORMATION TO REPORT AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1452322 G7 LONGEVITY HIGH WALL 32MM E PROSTHESIS, HIP LPH ZIMMER BIOMET, INC. NI 64615803 00889024519275

Patients

Seq Age Sex Outcome Treatment
1 63 YR Female Required Intervention| H SEE H10.